Literature DB >> 25924733

Long-Term Exposure to House Dust Mite Leads to the Suppression of Allergic Airway Disease Despite Persistent Lung Inflammation.

Sonali J Bracken1, Alexander J Adami, Steven M Szczepanek, Mohsin Ehsan, Prabitha Natarajan, Linda A Guernsey, Neda Shahriari, Ektor Rafti, Adam P Matson, Craig M Schramm, Roger S Thrall.   

Abstract

BACKGROUND: Allergic asthma is a major cause of worldwide morbidity and results from inadequate immune regulation in response to innocuous, environmental antigens. The need exists to understand the mechanisms that promote nonreactivity to human-relevant allergens such as house dust mite (HDM) in order to develop curative therapies for asthma. The aim of our study was to compare the effects of short-, intermediate- and long-term HDM administration in a murine asthma model and determine the ability of long-term HDM exposure to suppress allergic inflammation.
METHODS: C57BL/6 mice were intranasally instilled with HDM for short-term (2 weeks), intermediate-term (5 weeks) and long-term (11 weeks) periods to induce allergic airway disease (AAD). The severity of AAD was compared across all stages of the model via both immunological and pulmonary parameters.
RESULTS: Short- and intermediate-term HDM exposure stimulated the development of AAD that included eosinophilia in the bronchoalveolar lavage fluid (BALF), pronounced airway hyperreactivity (AHR) and evidence of lung inflammation. Long-term HDM exposure promoted the suppression of AAD, with a loss of BALF eosinophilia and AHR despite persistent mononuclear inflammation in the lungs. Suppression of AAD with long-term HDM exposure was associated with an increase in both Foxp3+ regulatory T cells and IL-10-positive alveolar macrophages at the site of inflammation.
CONCLUSIONS: This model recapitulates the key features of human asthma and may facilitate investigation into the mechanisms that promote immunological tolerance against clinically relevant aeroallergens.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25924733      PMCID: PMC4485530          DOI: 10.1159/000381058

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  59 in total

1.  Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity.

Authors:  Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Nat Med       Date:  2002-07-29       Impact factor: 53.440

2.  Phenotypic changes to the endogenous antigen-specific CD8+ T cell response correlates with the development and resolution of allergic airway disease.

Authors:  Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall
Journal:  Am J Pathol       Date:  2012-03-24       Impact factor: 4.307

3.  Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages.

Authors:  Shankar Subramanian Iyer; Amir Ali Ghaffari; Genhong Cheng
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

4.  IFN-γ acts on the airway epithelium to inhibit local and systemic pathology in allergic airway disease.

Authors:  Charlotte Mitchell; Karin Provost; Naiqian Niu; Robert Homer; Lauren Cohn
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

Review 5.  The regulation of allergy and asthma.

Authors:  Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

6.  Tolerance induced by chronic inhaled antigen in a murine asthma model is not mediated by endotoxin.

Authors:  C M Schramm; L Guernsey; E Secor; R S Thrall
Journal:  Biochim Biophys Acta       Date:  2006-03-09

7.  Chronic exposure to innocuous antigen in sensitized mice leads to suppressed airway eosinophilia that is reversed by granulocyte macrophage colony-stimulating factor.

Authors:  Filip K Swirski; Dusan Sajic; Clinton S Robbins; Beata U Gajewska; Manel Jordana; Martin R Stämpfli
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

8.  Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice.

Authors:  Chris L Van Hove; Tania Maes; Didier D Cataldo; Maud M Guéders; Els Palmans; Guy F Joos; Kurt G Tournoy
Journal:  Int Arch Allergy Immunol       Date:  2009-02-12       Impact factor: 2.749

9.  Accumulation of regulatory T cells in local draining lymph nodes of the lung correlates with spontaneous resolution of chronic asthma in a murine model.

Authors:  William F Carson; Linda A Guernsey; Anurag Singh; Anthony T Vella; Craig M Schramm; Roger S Thrall
Journal:  Int Arch Allergy Immunol       Date:  2007-10-04       Impact factor: 2.749

10.  Evaluation of the endotoxin binding efficiency of clay minerals using the Limulus Amebocyte lysate test: an in vitro study.

Authors:  Simone Schaumberger; Andrea Ladinig; Nicole Reisinger; Mathias Ritzmann; Gerd Schatzmayr
Journal:  AMB Express       Date:  2014-01-02       Impact factor: 3.298

View more
  14 in total

1.  Priming with high and low respiratory allergen dose induces differential CD4+ T helper type 2 cells and IgE/IgG1 antibody responses in mice.

Authors:  Kazuki Furuhashi; Yen L Chua; Kenneth H S Wong; Qian Zhou; Debbie C P Lee; Ka H Liong; Guo H Teo; Paul E Hutchinson; David M Kemeny
Journal:  Immunology       Date:  2017-04-03       Impact factor: 7.397

2.  IL-15-deficient mice develop enhanced allergic responses to airway allergen exposure.

Authors:  C B Mathias; C M Schramm; L A Guernsey; C A Wu; S H Polukort; J Rovatti; J Ser-Dolansky; E Secor; S S Schneider; R S Thrall; H L Aguila
Journal:  Clin Exp Allergy       Date:  2017-02-07       Impact factor: 5.018

3.  Secretoglobin Superfamily Protein SCGB3A2 Alleviates House Dust Mite-Induced Allergic Airway Inflammation in Mice.

Authors:  Mitsuhiro Yoneda; Lei Xu; Hiroaki Kajiyama; Shuko Kawabe; Jorge Paiz; Jerrold M Ward; Shioko Kimura
Journal:  Int Arch Allergy Immunol       Date:  2016-11-08       Impact factor: 2.749

4.  Efficacy of Optimized Treatment Protocol Using LAU-7b Formulation against Ovalbumin (OVA) and House Dust Mite (HDM) -Induced Allergic Asthma in Atopic Hyperresponsive A/J Mice.

Authors:  Mina Youssef; Juan B De Sanctis; Cynthia Kanagaratham; Shao Tao; Eisha Ahmed; Danuta Radzioch
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

5.  Significance of Foxp3+CD4+ regulatory T cells in the peripheral blood of Uygur patients in the acute and chronic phases of pigeon breeder's lung.

Authors:  Biqing Yu; Xiaohong Yang; Fengsen Li; Chao Wu; Wenyi Wang; Wei Ding
Journal:  Bosn J Basic Med Sci       Date:  2017-02-21       Impact factor: 3.363

6.  The IL-10GFP (VeRT-X) mouse strain is not suitable for the detection of IL-10 production by granulocytes during lung inflammation.

Authors:  Müge Özkan; Yusuf Cem Eskiocak; Gerhard Wingender
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

7.  The kinase p38α functions in dendritic cells to regulate Th2-cell differentiation and allergic inflammation.

Authors:  Miaomiao Han; Jingyu Ma; Suidong Ouyang; Yanyan Wang; Tingting Zheng; Peishan Lu; Zihan Zheng; Weiheng Zhao; Hongjin Li; Yun Wu; Baohua Zhang; Ran Hu; Kinya Otsu; Xinguang Liu; Ying Wan; Huabin Li; Gonghua Huang
Journal:  Cell Mol Immunol       Date:  2022-05-12       Impact factor: 22.096

8.  Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone.

Authors:  Mengli Ren; Min Feng; Zhimin Long; Jing Ma; Xuehua Peng; Guiqiong He
Journal:  Front Pharmacol       Date:  2021-06-23       Impact factor: 5.810

9.  A GATA3 Targeting Nucleic Acid Nanocapsule for In Vivo Gene Regulation in Asthma.

Authors:  Tyler D Gavitt; Alyssa K Hartmann; Shraddha S Sawant; Arlind B Mara; Steven M Szczepanek; Jessica L Rouge
Journal:  ACS Nano       Date:  2021-06-23       Impact factor: 18.027

Review 10.  Breathing Better Through Bugs: Asthma and the Microbiome.

Authors:  Alexander J Adami; Sonali J Bracken
Journal:  Yale J Biol Med       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.